Skip to content

Comparison of Efficacy Between a Newly Designed Covered Stent and Uncovered Stent for Malignant Colorectal Obstruction

Comparison of Efficacy Between a Newly Designed Covered Stent and Uncovered Stent for Malignant Colorectal Obstruction: a Prospective, Multicenter Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02640781
Enrollment
70
Registered
2015-12-29
Start date
2015-12-31
Completion date
2019-08-31
Last updated
2019-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

Acute colorectal obstruction has been reported to occur in 7 - 29% of all colorectal malignancies, but emergent surgical decompression is associated with high morbidity and mortality rates. Recently, self-expandable metal stents(SEMS) have been suggested as an alternative to surgery and effectively decompress the colonic obstruction and allow for bowel preparation and elective surgery. Theoretically, SEMSs are classified into uncovered stents and covered stents. Covered stents have the advantage of less frequent stent occlusion by tumor in-growth and the disadvantage of a high risk of stent migration, whereas uncovered stents are associated with less stent migration, although they appear to be more prone to tumor ingrowth. To overcome the drawbacks of conventional stents, a double-layered combination covered stent was developed. In the present study, the investigators evaluated the efficacy and safety of the newly designed covered stent by comparing it with the uncovered stent in patients with malignant colorectal obstruction.

Interventions

PROCEDUREself-expandable metal stent insertion(covered stent)

Stent insertion was performed by experienced endoscopists under fluoroscopy and by using through-the-scope methods. After the obstructing tumor was identified by endoscopy, a guidewire was introduced through the stricture under endoscopic and fluoroscopic controls. Then, the self-expandable colorectal covered stent delivery catheter was advanced through the working channel of the endoscope over the guidewire until the stent was positioned across the stricture. Upon releasing the stent delivery catheter, stent deployment was initiated proximally and progressed distally. Simple abdominal radiography was performed during and after the procedures to confirm proper stent placement and expansion.

PROCEDUREself-expandable metal stent insertion(uncovered stent)

Stent insertion was performed by experienced endoscopists under fluoroscopy and by using through-the-scope methods. After the obstructing tumor was identified by endoscopy, a guidewire was introduced through the stricture under endoscopic and fluoroscopic controls. Then, the self-expandable colorectal stent delivery uncovered catheter was advanced through the working channel of the endoscope over the guidewire until the stent was positioned across the stricture. Upon releasing the stent delivery catheter, stent deployment was initiated proximally and progressed distally. Simple abdominal radiography was performed during and after the procedures to confirm proper stent placement and expansion.

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* 20\ 85-year-old patients with malignant colorectal obstruction either by primary CRC or extracolonic malignancy * Patients with clinical obstructive symptoms confirmed by CT or colonoscopy

Exclusion criteria

* Patients with evidence of bowel perforation or peritonitis * Cause of obstruction other than malignancy (bowel adhesion or benign stricture) * Multiple stricture * Lower rectal cancer obstruction (AV \<5cm)

Design outcomes

Primary

MeasureTime frameDescription
Duration of stent patency between stent insertion and recurrence of obstructive symptoms2 years after the procedureTime between stent insertion and recurrence of obstructive symptoms caused by tumor ingrowth, tumor overgrowth, or stent migration after stent placement

Secondary

MeasureTime frameDescription
Number of patients with technical success2 years after the procedureTechnical success: Adequate deployment across the entire length of the malignant strictures and proper stent expansion
Number of patients with clinical success2 years after the procedureClinical success: Relief from obstructive symptoms as a result of sufficient improvement in stool passage without additional need for endoscopic or surgical re-intervention within 48 hours
Number of patients with complications2 years after the procedureComplications: stent obstruction, migration, perforation, bleeding, tenesmus, anal pain

Countries

South Korea

Contacts

Primary ContactTae-Il Kim, MD, Ph.D
taeilkim@yuhs.ac82-2-2228-1965

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026